| Literature DB >> 29326919 |
Anna Sannino1, Stefania Romeo1, Maria Rosaria Scarfì1, Rita Massa1,2, Raffaele d'Angelo3, Antonella Petrillo4, Vincenzo Cerciello5, Roberta Fusco4, Olga Zeni1.
Abstract
Magnetic resonance imaging (MRI) has evolved rapidly over the past few decades as one of the most flexible tools in medical research and diagnostic imaging. MRI facilities are important sources of multiple exposure to electromagnetic fields for both patients and health-care staff, due to the presence of electromagnetic fields of multiple frequency ranges, different temporal variations, and field strengths. Due to the increasing use and technological advancements of MRI systems, clearer insights into exposure assessment and a better understanding of possible harmful effects due to long-term exposures are highly needed. In the present exploratory study, exposure assessment and biomonitoring of MRI workers at the Radio-diagnostics Unit of the National Cancer Institute of Naples "Pascale Foundation" (Naples, Italy) have been carried out. In particular, exposure to the MRI static magnetic field (SMF) has been evaluated by means of personal monitoring, while an application tool has been developed to provide an estimate of motion-induced, time-varying electric fields. Measurement results have highlighted a high day-to-day and worker-to-worker variability of the exposure to the SMF, which strongly depends on the characteristics of the environment and on personal behaviors, and the developed application tool can be adopted as an easy-to-use tool for rapid and qualitative evaluation of motion-induced, time-varying electric field exposure. Regarding biomonitoring, the 24 workers of the Radio-diagnostics Unit were enrolled to evaluate both spontaneous and mitomycin C-induced chromosomal fragility in human peripheral blood lymphocytes, by means of the cytokinesis-block micronucleus assay. The study subjects were 12 MRI workers, representative of different professional categories, as the exposed group, and 12 workers with no MRI exposure history, as the reference group. The results show a high worker-to-worker variability for both field exposure assessment and biomonitoring, as well as several critical issues and practicalities to be faced with in this type of investigations. The procedures for risk assessment and biomonitoring proposed here can be used to inform future research in this field, which will require a refinement of exposure assessment methods and an enlargement of the number of subjects enrolled in the biomonitoring study to gain robust statistics and reliable results.Entities:
Keywords: exposure assessment; human lymphocytes; magnetic resonance imaging; micronucleus assay; mitomycin C; occupational exposure
Year: 2017 PMID: 29326919 PMCID: PMC5741817 DOI: 10.3389/fpubh.2017.00344
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
The main characteristics of the donors enrolled in the study.
| Parameter | Exposed subject | Control subject |
|---|---|---|
| 12 | 12 | |
| Technician | 4 | 5 |
| Health-care assistant | 4 | 5 |
| Cleaning personnel | 2 | – |
| Medical director | 2 | 2 |
| Mean ± SD | 47.25 ± 9.65 | 38.25 ± 13.9 |
| Range | 35–62 | 23–61 |
| Male % | 50 | 58 |
| Female % | 50 | 42 |
| Non-smokers % | 50 | 66 |
| Smokers % | 50 | 34 |
| Mean ± SD | 11.7 ± 5.35 | – |
| Range | 5–20 | |
| Mean ± SD | 10.3 ± 5.33 | |
| Range | 3–21 | |
| Family history of cancer | – | – |
Spontaneous micronuclei (MN) incidence and proliferation index (PI) in human peripheral blood lymphocytes from magnetic resonance imaging (MRI) exposed group and control group.
| MRI-exposed group | Control group | ||||||
|---|---|---|---|---|---|---|---|
| Donor | BC with MN | Total MN | PI | Donor | BC with MN | Total MN | PI |
| 1 | 17 | 18 | 1.66 | 1 | 26 | 29 | 1.82 |
| 2 | 10 | 10 | 1.70 | 2 | 15 | 16 | 1.87 |
| 3 | 19 | 19 | 1.70 | 3 | 12 | 13 | 1.57 |
| 4 | 17 | 18 | 1.59 | 4 | 21 | 21 | 1.86 |
| 5 | 11 | 13 | 1.80 | 5 | 9 | 9 | 1.60 |
| 6 | 8 | 8 | 1.70 | 6 | 5 | 5 | 2.10 |
| 7 | 12 | 14 | 1.77 | 7 | 5 | 5 | 1.61 |
| 8 | 9 | 10 | 1.69 | 8 | 7 | 8 | 1.46 |
| 9 | 8 | 8 | 1.76 | 9 | 11 | 11 | 1.60 |
| 10 | 10 | 10 | 1.87 | 10 | 8 | 8 | 1.89 |
| 11 | 8 | 9 | 1.63 | 11 | 19 | 20 | 1.76 |
| 12 | 5 | 5 | 1.95 | 12 | 7 | 7 | 1.80 |
| Mean ± SD | 11.17 ± 4.3 | 11.83 ± 4.6 | 1.73 ± 0.10 | Mean ± SD | 12.08 ± 6.8 | 12.67 ± 7.5 | 1.74 ± 0.18 |
For each donor, 2,000 binucleated cells (BC) and 500 total cells were scored to derive MN incidence and PI, respectively.
Mitomycin C (100 ng/ml)-induced micronuclei (MN) and proliferation index (PI) in human peripheral blood lymphocytes from magnetic resonance imaging (MRI)-exposed group and control group.
| MRI-exposed group | Control group | ||||||
|---|---|---|---|---|---|---|---|
| Donor | BC with MN | Total MN | PI | Donor | BC with MN | Total MN | PI |
| 1 | 58 | 65 | 1.47 | 1 | 35 | 36 | 1.45 |
| 2 | 55 | 62 | 1.48 | 2 | 43 | 43 | 1.60 |
| 3 | 30 | 31 | 1.52 | 3 | 29 | 30 | 1.32 |
| 4 | 41 | 43 | 1.41 | 4 | 44 | 46 | 1.00 |
| 5 | 39 | 42 | 1.58 | 5 | 32 | 33 | 1.50 |
| 6 | 24 | 24 | 1.42 | 6 | 28 | 28 | 1.55 |
| 7 | 23 | 23 | 1.53 | 7 | 27 | 29 | 1.48 |
| 8 | 23 | 26 | 1.53 | 8 | 21 | 23 | 1.47 |
| 9 | 20 | 20 | 1.49 | 9 | 28 | 28 | 1.50 |
| 10 | 25 | 27 | 1.68 | 10 | 39 | 41 | 1.77 |
| 11 | 26 | 27 | 1.51 | 11 | 54 | 56 | 1.55 |
| 12 | 43 | 43 | 1.60 | 12 | 35 | 35 | 1.70 |
| Mean ± SD | 33.92 ± 13.0 | 36.08 ± 15.1 | 1.52 ± 0.07 | Mean ± SD | 34.58 ± 9.2 | 35.67 ± 9.4 | 1.49 ± 0.19 |
For each donor, 2,000 binucleated cells (BC) and 500 total cells were scored to derive MN incidence and PI, respectively.
Figure 1Daily peak value of magnetic flux density (B) experienced by four workers, measured over a period of 2 weeks (11 days of work, except for magnetic resonance imaging technician 1, blue line, for which data of 1 day were corrupted; estimated uncertainty: 2%).
Figure 2Reconstruction of the iso-gauss lines map at the height of the central axis of the scanner and representative pathways (white, dashed arrows) of workers’ movements in the magnetic resonance imaging suite.
Figure 3Absolute value of the induced E-field (A) and of dB/dt (B) and amplitude spectra of dB/dT (C) calculated for path 1 and path 2.
Figure 4Micronuclei (MN) incidence in 2,000 binucleated cells [BCs, (A)] and proliferation index [PI, (B)] in 500 cells of control workers treated with increasing doses of mitomycin C (MMC; mean ± SD of four donors). *P < 0.05 (analysis of variance).